Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Journal of Palliative Medicine
|
December 1, 2021
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors
Cameron Chalker, Rafael Santana-Davila, Jenna M Voutsinas, et al.
Advances in Radiation Oncology
|
April 7, 2022
Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer
Stephen R Bowen, Daniel S Hippe, Hannah M Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2013
Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial
Renato G Martins, Upendra Parvathaneni, Julie E Bauman, et al.
The Journal of Molecular Diagnostics : JMD
|
November 6, 2013
Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens
Colin C Pritchard, Stephen J Salipante, Karen Koehler, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 31, 2025
Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer
Natalie J Miller, Christina S Baik, Joel W Neal, et al.
Head & Neck
|
April 25, 2025
Dual PD-1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland Cancers
Cristina P Rodriguez, Qian Vicky Wu, Kevin Ng, et al.
Journal for Immunotherapy of Cancer
|
July 15, 2025
Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer
Natalie J Miller, Christina Baik, Joel W Neal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 14, 2011
NCCN Clinical Practice Guidelines Occult primary
David S Ettinger, Mark Agulnik, Justin M M Cates, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 5, 2014
Occult primary, version 3.2014
David S Ettinger, Charles R Handorf, Mark Agulnik, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Journal of Palliative Medicine
|
December 1, 2021
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors
Cameron Chalker, Rafael Santana-Davila, Jenna M Voutsinas, et al.
Advances in Radiation Oncology
|
April 7, 2022
Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer
Stephen R Bowen, Daniel S Hippe, Hannah M Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2013
Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial
Renato G Martins, Upendra Parvathaneni, Julie E Bauman, et al.
The Journal of Molecular Diagnostics : JMD
|
November 6, 2013
Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens
Colin C Pritchard, Stephen J Salipante, Karen Koehler, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 31, 2025
Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer
Natalie J Miller, Christina S Baik, Joel W Neal, et al.
Head & Neck
|
April 25, 2025
Dual PD-1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland Cancers
Cristina P Rodriguez, Qian Vicky Wu, Kevin Ng, et al.
Journal for Immunotherapy of Cancer
|
July 15, 2025
Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer
Natalie J Miller, Christina Baik, Joel W Neal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 14, 2011
NCCN Clinical Practice Guidelines Occult primary
David S Ettinger, Mark Agulnik, Justin M M Cates, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 5, 2014
Occult primary, version 3.2014
David S Ettinger, Charles R Handorf, Mark Agulnik, et al.
Page
of 6